The US Food and Drug Administration has “no questions” in regards to Renaissance’s Generally Regarded as Safe (GRAS) notice for its non-GMO, acrylamide-reducing (AR) baker’s yeast strain.
“The acceptance of our acrylamide-reducing yeast as GRAS by the U.S. FDA is a significant step forward in the commercialization and marketing of the AR yeast for a wide variety of food and beverage sectors,” said Dr. John Husnik, CEO of Renaissance BioScience.
“GRAS status provides further validation to food manufacturers worldwide to apply our innovative AR yeast to address the acrylamide problem that continues to be a concern in many foods and beverages,” said CEO Dr. John Husnik.
“In foods that already contain yeast we believe our AR yeast can quickly and seamlessly replace the use of conventional baker’s yeast, with minimal or no change to the food production process, thereby reducing the amount of acrylamide in the final consumer product by up to 90%.”
“For foods that do not traditionally contain yeast it is also possible to significantly reduce acrylamide levels using our AR yeast by making reasonable process alterations, as our laboratory results have shown.”
The AR yeast now joins other mainstream ingredients, such as conventional baker’s yeast and other food and beverage yeasts, that have GRAS status.
